Prediction of effects of calcium channel blockers (CCB) on hypoxic pulmonary hypertension (HPH) due to COPD Source: Eur Respir J 2003; 22: Suppl. 45, 268s Year: 2003
Loss of response to calcium channel blockers after long-term follow up in idiopathic pulmonary arterial hypertension Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020
Effect of the KCa3.1 k+ channels blocker triarylmethane-34 in a murine model of chronic asthma Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009
Effects of duramycin on cardiac voltage-gated ion channels Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009
Role of NO pathway, calcium and potassium channels in the peripheral pulmonary vascular tone in dogs Source: Eur Respir J 2001; 17: 20-26 Year: 2001
Using cardioselective beta-blockers in patients with cardiovascular diseases and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 294s Year: 2005
The chloride channel: pathology and specific therapy Source: International Congress 2015 – Cystic fibrosis: not just for the specialists Year: 2015
Beta blocker prescription in patients with coexisting cardiac and obstructive airways disease Source: Eur Respir J 2004; 24: Suppl. 48, 278s Year: 2004
The pathophysiological roles of a voltage-gated potassium channel Kv1.5 in toluene diisocyanate-induced asthma Source: Eur Respir J 2002; 20: Suppl. 38, 29s Year: 2002
Using cardioselective beta-blockers in patients with cardiovascular diseases and asthma Source: Eur Respir J 2007; 30: Suppl. 51, 69s Year: 2007
Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats Source: Eur Respir J 2003; 21: 862-865 Year: 2003
SUR1/Kir6.2 potassium channel a new actor involved in pulmonary arterial hypertension Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020
Beta blockers in heart failure and airways disease Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010
The potential effects of pregnancy in a patient with idiopathic pulmonary arterial hypertension responding to calcium channel blockade Source: Eur Respir J, 50 (6) 1701141; 10.1183/13993003.01141-2017 Year: 2017
The conductability of potassium ion channels on lymphocytes T in atopic patients with pollinosis and in chronic asthma and aspirin induced asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 230s Year: 2006
Cardiohemodynamics changes in COPD patients while using blockers of AT1 receptors to angiotensin II Source: Eur Respir J 2006; 28: Suppl. 50, 105s Year: 2006
Clinical and inhaled drug profile of COPD patients with indication for beta-blockers who are on beta-blockers Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013
LATE-BREAKING ABSTRACT: Inhibition of ATP-gated P2X3 channels by AF-219: An effective anti-tussive mechanism in chronic cough Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013
Impact of blockers of AT1 receptors to angiotensin II on endothelium vasoregulating function in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 739s Year: 2006
Properties of a store-operated no nselective cation channel in airway smooth muscle Source: Eur Respir J 2008; 32: 1529-1538 Year: 2008